Filed: 11/13/2024ACC: 0002042586-24-000002
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $261.07M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$261.07M
Total AUM (reported)
20.96M
Total Shares
Allocation by class
COM$213.89M81.9%
SPONSORED ADS$38.17M14.6%
COM CL A$5.82M2.2%
COM NEW$3.19M1.2%
Portfolio Concentration
Top 3$206.31M79.0%
4–10$47.79M18.3%
11–25$6.97M2.7%
Top 3 weight
79.0%
Top 10 weight
97.3%
Voting Authority Distribution
Total shares with voting rights: 20.96M
Sole
Full voting authority
20.96M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$154.49M
59.18%
Sole
6.07M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares1.12M
TypeSH
Market value$32.09M
12.29%
Sole
1.12M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$19.73M
7.56%
Sole
1.02M
Shared
0.00
None
0.00
Bicara Therapeutics Inc. (BCAX)
SOLEShares568.92K
TypeSH
Market value$14.49M
5.55%
Sole
568.92K
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares798.76K
TypeSH
Market value$8.07M
3.09%
Sole
798.76K
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.47M
TypeSH
Market value$7.80M
2.99%
Sole
1.47M
Shared
0.00
None
0.00
Compass Pathways Plc (CMPS)
SOLEShares964.50K
TypeSH
Market value$6.08M
2.33%
Sole
964.50K
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$5.82M
2.23%
Sole
2.54M
Shared
0.00
None
0.00
Poseida Therapeutics Inc. (PSTX)
SOLEShares1.04M
TypeSH
Market value$2.98M
1.14%
Sole
1.04M
Shared
0.00
None
0.00
Tectonic Therapeutic Inc (TECX)
SOLEShares84.15K
TypeSH
Market value$2.55M
0.98%
Sole
84.15K
Shared
0.00
None
0.00
CalciMedica, Inc. (CALC)
SOLEShares521.11K
TypeSH
Market value$2.31M
0.88%
Sole
521.11K
Shared
0.00
None
0.00
Elevation Oncology Inc (ELEV)
SOLEShares2.83M
TypeSH
Market value$1.70M
0.65%
Sole
2.83M
Shared
0.00
None
0.00
Reneo Pharmaceuticals Inc (RPHM)
SOLEShares886.08K
TypeSH
Market value$1.51M
0.58%
Sole
886.08K
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares314.29K
TypeSH
Market value$886.3K
0.34%
Sole
314.29K
Shared
0.00
None
0.00
Aclaris Therapeutics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$499.6K
0.19%
Sole
434.45K
Shared
0.00
None
0.00
Viracta Therapeutics Inc (VIRX)
SOLEShares288.57K
TypeSH
Market value$66.4K
0.03%
Sole
288.57K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $154.49M 59.18% | 6.07M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 1.12M | SH | $32.09M 12.29% | 1.12M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $19.73M 7.56% | 1.02M | 0.00 | 0.00 |
Bicara Therapeutics Inc. (BCAX)SOLE | COM | 568.92K | SH | $14.49M 5.55% | 568.92K | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 798.76K | SH | $8.07M 3.09% | 798.76K | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.47M | SH | $7.80M 2.99% | 1.47M | 0.00 | 0.00 |
Compass Pathways Plc (CMPS)SOLE | SPONSORED ADS | 964.50K | SH | $6.08M 2.33% | 964.50K | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $5.82M 2.23% | 2.54M | 0.00 | 0.00 |
Poseida Therapeutics Inc. (PSTX)SOLE | COM | 1.04M | SH | $2.98M 1.14% | 1.04M | 0.00 | 0.00 |
Tectonic Therapeutic Inc (TECX)SOLE | COM | 84.15K | SH | $2.55M 0.98% | 84.15K | 0.00 | 0.00 |
CalciMedica, Inc. (CALC)SOLE | COM NEW | 521.11K | SH | $2.31M 0.88% | 521.11K | 0.00 | 0.00 |
Elevation Oncology Inc (ELEV)SOLE | COM | 2.83M | SH | $1.70M 0.65% | 2.83M | 0.00 | 0.00 |
Reneo Pharmaceuticals Inc (RPHM)SOLE | COM | 886.08K | SH | $1.51M 0.58% | 886.08K | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM NEW | 314.29K | SH | $886.3K 0.34% | 314.29K | 0.00 | 0.00 |
Aclaris Therapeutics Inc (ACRS)SOLE | COM | 434.45K | SH | $499.6K 0.19% | 434.45K | 0.00 | 0.00 |
Viracta Therapeutics Inc (VIRX)SOLE | COM | 288.57K | SH | $66.4K 0.03% | 288.57K | 0.00 | 0.00 |